D
DXB
DIMERIX LTD
0.39
0.04+10.00%Closed16:10 03/17 AEDT
OPEN/PREV CLOSE0.365/0.350
TODAY RANGE0.347-0.395
VOL2.08M
MARKET CAP231.15M
52 WEEK RANGE0.335-0.785
AVG VOL (3M)1.67M
% TURNOVER0.35%
TURNOVER766.61K
P/E (TTM)-14.1544
% RANGE13.71%
EPS(TTM)-0.0272
P/E(FORWARD)-26.2500
P/B-137.5000
BVPS-0.0028
DIVIDEND--
P/S38.89
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP175.53M
SHARES OUTSTANDING600.40M
NEXT EARNINGS--
FREE FLOAT455.93M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
ASX·03/09 22:22
Dimerix Phase 3 Trial Last Patient Receives First Dose
ASX·03/03 22:39
Dimerix Invitation to Perth and Singapore Investor Briefings
ASX·02/26 22:26
Dimerix Presents at Oppenheimer Life Sciences Conference
ASX·02/25 22:32
Appendix 4D and Half Year Financial Report
ASX·02/04 22:29
Dimerix to Present at Euroz Hartleys Healthcare Forum 2026
Dow Jones·01/30 05:54
*Dimerix Price Target Cut 1.8% to A$1.65/Share by Euroz Hartleys
ASX·01/28 22:39
Quarterly Appendix 4C and Activities Report
ASX·01/20 21:30
Appointment of CFO/Company Secretary
ASX·01/11 21:30
Clinical trial update at J.P. Morgan Healthcare Conference
ASX·12/23/2025 21:38
Dimerix receives input from FDA on ACTION3 trial endpoints
ASX·12/21/2025 22:18
BioMarin to acquire Dimerix US Partner, Amicus Therapeutics
ASX·12/14/2025 21:47
DMX-200 ACTION3 Phase 3 Trial Completes Recruitment
ASX·12/12/2025 03:52
Change of Director's Interest Notice - CS,HA,NW,SP & MD
Same Industry
Name/Symbol
Change%
Price
No data yet, let's see others